These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 24997148)

  • 1. Serum ferritin level and morbidity risk in transfusion-independent patients with β-thalassemia intermedia: the ORIENT study.
    Musallam KM; Cappellini MD; Daar S; Karimi M; El-Beshlawy A; Graziadei G; Magestro M; Wulff J; Pietri G; Taher AT
    Haematologica; 2014 Nov; 99(11):e218-21. PubMed ID: 24997148
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum Hepcidin as a Diagnostic Marker of Severe Iron Overload in Beta-thalassemia Major.
    Kaddah AM; Abdel-Salam A; Farhan MS; Ragab R
    Indian J Pediatr; 2017 Oct; 84(10):745-750. PubMed ID: 28600663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum ferritin levels and endocrinopathy in medically treated patients with β thalassemia major.
    Belhoul KM; Bakir ML; Saned MS; Kadhim AM; Musallam KM; Taher AT
    Ann Hematol; 2012 Jul; 91(7):1107-14. PubMed ID: 22281991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iron overload in β-thalassemia intermedia: an emerging concern.
    Musallam KM; Cappellini MD; Taher AT
    Curr Opin Hematol; 2013 May; 20(3):187-92. PubMed ID: 23426199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum ferritin is not a reliable predictor to determine iron overload in thalassemia major patients post-hematopoietic stem cell transplantation.
    Jarisch A; Salzmann-Manrique E; Cario H; Grosse R; Soerensen J; Fischer R; Schulz A; Hammerstingl R; Wunderlich A; Bader P
    Eur J Haematol; 2018 Dec; 101(6):791-797. PubMed ID: 30187571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Erythroferrone, Hepcidin, and Iron Overload Status in Iraqi Transfusion-Dependent β-Thalassemia Major Patients.
    Smesam HNK; Albuthabhak HAQ; Arjmand S; Al-Hakeim HK; R Siadat SO
    Hemoglobin; 2020 Jul; 44(4):272-277. PubMed ID: 32718192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-transferrin-bound labile plasma iron and iron overload in sickle-cell disease: a comparative study between sickle-cell disease and beta-thalassemic patients.
    Koren A; Fink D; Admoni O; Tennenbaum-Rakover Y; Levin C
    Eur J Haematol; 2010 Jan; 84(1):72-8. PubMed ID: 19732137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined therapy with desferrioxamine and deferiprone in beta thalassemia major patients with transfusional iron overload.
    Daar S; Pathare AV
    Ann Hematol; 2006 May; 85(5):315-9. PubMed ID: 16450126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of HFE Gene Mutations With Serum Ferritin Level and Heart and Liver Iron Overload in Patients With Transfusion-dependent Beta-Thalassemia.
    Zekavat OR; Zareian Jahromi M; Haghpanah S; Kargar Jahromi Z; Cohan N
    J Pediatr Hematol Oncol; 2021 Jan; 43(1):e26-e28. PubMed ID: 32925401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of Deferasirox (Exjade®) in Modulation of Iron Overload in Patients with β-Thalassemia Intermedia.
    Karimi M; Arandi N; Haghpanah S; Ansari S; Azarkeyvan A; Bordbar M; Safaei S
    Hemoglobin; 2015; 39(5):327-9. PubMed ID: 26114738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endocrinopathies, metabolic disorders, and iron overload in major and intermedia thalassemia: serum ferritin as diagnostic and predictive marker associated with liver and cardiac T2* MRI assessment.
    Chirico V; Rigoli L; Lacquaniti A; Salpietro V; Piraino B; Amorini M; Salpietro C; Arrigo T
    Eur J Haematol; 2015 May; 94(5):404-12. PubMed ID: 25200112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver iron concentrations and urinary hepcidin in beta-thalassemia.
    Origa R; Galanello R; Ganz T; Giagu N; Maccioni L; Faa G; Nemeth E
    Haematologica; 2007 May; 92(5):583-8. PubMed ID: 17488680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extramedullary Hematopoiesis in β-Thalassemia.
    Kalchiem-Dekel O; Greenbaum U
    Mayo Clin Proc; 2015 Nov; 90(11):1591-2. PubMed ID: 26541258
    [No Abstract]   [Full Text] [Related]  

  • 14. Investigation of correlation between H63D and C282Y mutations in HFE gene and serum Ferritin level in beta-thalassemia major patients.
    Rahmani R; Naseri P; Safaroghli-Azar A; Tarighi S; Hosseini T; Hojjati MT
    Transfus Clin Biol; 2019 Nov; 26(4):249-252. PubMed ID: 31679808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the 5mg/g liver iron concentration threshold and its association with morbidity in patients with β-thalassemia intermedia.
    Musallam KM; Cappellini MD; Taher AT
    Blood Cells Mol Dis; 2013 Jun; 51(1):35-8. PubMed ID: 23425967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac complications and iron overload in beta thalassemia major patients-a systematic review and meta-analysis.
    Koohi F; Kazemi T; Miri-Moghaddam E
    Ann Hematol; 2019 Jun; 98(6):1323-1331. PubMed ID: 30729283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue Doppler echocardiography reliably reflects severity of iron overload in pediatric patients with beta thalassemia.
    Silvilairat S; Sittiwangkul R; Pongprot Y; Charoenkwan P; Phornphutkul C
    Eur J Echocardiogr; 2008 May; 9(3):368-72. PubMed ID: 17689292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum ferritin levels and irregular use of iron chelators predict liver iron load in patients with major beta thalassemia: a cross-sectional study.
    Sobhani S; Rahmani F; Rahmani M; Askari M; Kompani F
    Croat Med J; 2019 Oct; 60(5):405-413. PubMed ID: 31686454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment and complications of thalassemia major in Guangxi, Southern China.
    Yin XL; Wu ZK; He YY; Zhou TH; Zhou YL; Zhang XH
    Pediatr Blood Cancer; 2011 Dec; 57(7):1174-8. PubMed ID: 21394896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response to hydroxycarbamide in pediatric β-thalassemia intermedia: 8 years' follow-up in Egypt.
    El-Beshlawy A; El-Ghamrawy M; EL-Ela MA; Said F; Adolf S; Abdel-Razek AR; Magdy RI; Abdel-Salam A
    Ann Hematol; 2014 Dec; 93(12):2045-50. PubMed ID: 25062719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.